Magnetic Resonance Imaging and Computed Tomography Findings in Pediatric Giant Cell Glioblastoma

Overview

Journal Clin Neuroradiol

Specialties Neurology
Radiology

Date 2012 Jan 31

PMID 22286149

Citations 3

Authors

L Zipp

K M Schwartz

E Hewer

Y Yu

C Stippich

J M Slopis

Affiliations

Soon will be listed here.

Citing Articles

The 2021 World Health Organization Central Nervous System Tumor Classification: The Spectrum of Diffuse Gliomas.

Gue R, Lakhani D Biomedicines. 2024; 12(6).

PMID: 38927556 PMC: 11202067. DOI: 10.3390/biomedicines12061349.

Pediatric Giant Cell Glioblastoma Presenting with Intracranial Dissemination at Diagnosis: A Case Report.

Kinoshita T, Yano H, Nakayama N, Suzui N, Iida T, Endo S NMC Case Rep J. 2022; 8(1):151-157.

PMID: 35079457 PMC: 8769385. DOI: 10.2176/nmccrj.cr.2020-0138.

Imaging findings in the progression of a giant cell glioblastoma.

Turner R, Matthys S, Heymann J, Gelman B Radiol Case Rep. 2018; 13(5):1007-1011.

PMID: 30128062 PMC: 6097408. DOI: 10.1016/j.radcr.2018.07.010.

References

Martinez-Diaz H, Kleinschmidt-DeMasters B, Powell S, Yachnis A . Giant cell glioblastoma and pleomorphic xanthoastrocytoma show different immunohistochemical profiles for neuronal antigens and p53 but share reactivity for class III beta-tubulin. Arch Pathol Lab Med. 2003; 127(9):1187-91. DOI: 10.5858/2003-127-1187-GCGAPX. View

Kawano H, Kubota T, Sato K, Goya T, Arikawa S, Wakisaka S . Immunohistochemical study of giant cell in glioblastoma. Clin Neuropathol. 1995; 14(2):118-23. View

Hegi M, Diserens A, Gorlia T, Hamou M, De Tribolet N, Weller M . MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005; 352(10):997-1003. DOI: 10.1056/NEJMoa043331. View

de Prada I, Cordobes F, Azorin D, Contra T, Colmenero I, Glez-Mediero I . Pediatric giant cell glioblastoma: a case report and review of the literature. Childs Nerv Syst. 2005; 22(3):285-9. DOI: 10.1007/s00381-005-1178-5. View

Bauchet L, Mathieu-Daude H, Fabbro-Peray P, Rigau V, Fabbro M, Chinot O . Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004. Neuro Oncol. 2010; 12(7):725-35. PMC: 2940657. DOI: 10.1093/neuonc/noq030. View

Kleihues P, Louis D, Scheithauer B, Rorke L, Reifenberger G, Burger P . The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol. 2002; 61(3):215-25; discussion 226-9. DOI: 10.1093/jnen/61.3.215. View

Margetts J . Giant-celled glioblastoma of brain. A clinico-pathological and radiological study of ten cases (including immunohistochemistry and ultrastructure). Cancer. 1989; 63(3):524-31. DOI: 10.1002/1097-0142(19890201)63:3<524::aid-cncr2820630321>3.0.co;2-d. View

Pollack I, Hamilton R, Burnham J, Holmes E, Finkelstein S, Sposto R . Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort. Neurosurgery. 2002; 50(6):1238-44; discussion 1244-5. DOI: 10.1097/00006123-200206000-00011. View

Karremann M, Butenhoff S, Rausche U, Pietsch T, Wolff J, Kramm C . Pediatric giant cell glioblastoma: New insights into a rare tumor entity. Neuro Oncol. 2008; 11(3):323-9. PMC: 2718977. DOI: 10.1215/15228517-2008-099. View

10.

Filippini G, Falcone C, Boiardi A, Broggi G, Bruzzone M, Caldiroli D . Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma. Neuro Oncol. 2007; 10(1):79-87. PMC: 2600841. DOI: 10.1215/15228517-2007-038. View

11.

Chaichana K, Chaichana K, Olivi A, Weingart J, Bennett R, Brem H . Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survival. Clinical article. J Neurosurg. 2010; 114(3):587-94. PMC: 4020429. DOI: 10.3171/2010.8.JNS1081. View

12.

Sabel M, Reifenberger J, Weber R, Reifenberger G, Schmitt H . Long-term survival of a patient with giant cell glioblastoma. Case report. J Neurosurg. 2001; 94(4):605-11. DOI: 10.3171/jns.2001.94.4.0605. View

13.

Deb P, Sharma M, Chander B, Mahapatra A, Sarkar C . Giant cell glioblastoma multiforme: report of a case with prolonged survival and transformation to gliosarcoma. Childs Nerv Syst. 2005; 22(3):314-9. DOI: 10.1007/s00381-005-1239-9. View

14.

Cimini A, Ippoliti R . Innovative Therapies against Human Glioblastoma Multiforme. ISRN Oncol. 2011; 2011:787490. PMC: 3195804. DOI: 10.5402/2011/787490. View

15.

Peraud A, Watanabe K, Schwechheimer K, Yonekawa Y, Kleihues P, Ohgaki H . Genetic profile of the giant cell glioblastoma. Lab Invest. 1999; 79(2):123-9. View

16.

Artico M, Cervoni L, Celli P, Salvati M, Palma L . Supratentorial glioblastoma in children: a series of 27 surgically treated cases. Childs Nerv Syst. 1993; 9(1):7-9. DOI: 10.1007/BF00301926. View

17.

Bucci M, Maity A, Janss A, Belasco J, Fisher M, Tochner Z . Near complete surgical resection predicts a favorable outcome in pediatric patients with nonbrainstem, malignant gliomas: results from a single center in the magnetic resonance imaging era. Cancer. 2004; 101(4):817-24. DOI: 10.1002/cncr.20422. View

18.

Raco A, Bristot R, Salvati M, Delfini R . Malignant supratentorial astrocytomas of late childhood. Our experience with 25 cases. Childs Nerv Syst. 1997; 13(6):341-4. DOI: 10.1007/s003810050093. View

19.

Klein R, Molenkamp G, Sorensen N, Roggendorf W . Favorable outcome of giant cell glioblastoma in a child. Report of an 11-year survival period. Childs Nerv Syst. 1998; 14(6):288-91. DOI: 10.1007/s003810050228. View

20.

Mirimanoff R, Gorlia T, Mason W, van den Bent M, Kortmann R, Fisher B . Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial. J Clin Oncol. 2006; 24(16):2563-9. DOI: 10.1200/JCO.2005.04.5963. View